Dietary soy and tea mitigate chronic inflammation and prostate cancer via NFκB pathway in the Noble rat model

Journal of Nutritional Biochemistry

Volumn 22, Issue 5, 2011, Pages 502-510

  Hsu, Anna ^a   Bruno, Richard S ^b   Löhr, Christiane V ^a   Taylor, Alan W ^c   Dashwood, Rodrick H ^a,c   Bray, Tammy M ^a,c   Ho, Emily ^a,c  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Green tea; Inflammation; Noble rat; Nuclear factor kappa B; Prostate cancer; Soy

Indexed keywords

DAIDZEIN; EQUOL; ESTRADIOL; GENISTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P50; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIETARY INTAKE; IN VIVO STUDY; MALE; NOBLE RAT; NONHUMAN; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; RAT; SOYBEAN; TEA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; BCL-2-ASSOCIATED X PROTEIN; CATECHIN; CHRONIC DISEASE; DIET; DISEASE MODELS, ANIMAL; ESTRADIOL; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; ISOFLAVONES; MALE; NF-KAPPA B; PROSTATIC NEOPLASMS; RATS; SIGNAL TRANSDUCTION; SOY FOODS; SOYBEANS; TEA; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 79954619217     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2010.04.006     Document Type: Article

References (65)

1. Jemal A., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58(2):71-96.
2. Muir C.S., Nectoux J., Staszewski J. The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol 1991, 30(2):133-140.
3. Cook L.S., et al. Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J Urol 1999, 161(1):152-155.
4. Lamartiniere C.A. Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr 2000, 71(6 Suppl):1705S-1707S. [discussion 1708S-9S].
5. Gilani G.S., Anderson J.B. Phytoestrogens and Health 2002, 660. AOCS Press, Champaign, IL. G.S. Gilani, J.J.B. Anderson (Eds.).
6. Dixon R.A. Phytoestrogens. Annu Rev Plant Biol 2004, 55:225-261.
7. Fujiki H., et al. Cancer inhibition by green tea. Mutat Res 1998, 402(1-2):307-310.
8. Inoue M., et al. Tea and coffee consumption and the risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control 1998, 9(2):209-216.
9. Ji B.T., et al. Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 1997, 70(3):255-258.
10. Nakachi K., et al. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res 1998, 89(3):254-261.
11. Beltz L.A., et al. Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem 2006, 6(5):389-406.
12. Handayani R., et al. Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells. J Nutr 2006, 136(1):75-82.
13. Fotsis T., et al. Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J Nutr 1995, 125(3 Suppl):790S-797S.
14. Zhu B.H., et al. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis. World J Gastroenterol 2007, 13(8):1162-1169.
15. Adhami V.M., Ahmad N., Mukhtar H. Molecular targets for green tea in prostate cancer prevention. J Nutr 2003, 133(7 Suppl):2417S-2424S.
16. Cooke P.S., Selvaraj V., Yellayi S. Genistein, estrogen receptors, and the acquired immune response. J Nutr 2006, 136(3):704-708.
17. Greten F.R., et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004, 118(3):285-296.
18. Pikarsky E., et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004, 431(7007):461-466.
19. Luo J.L., et al. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 2007, 446(7136):690-694.
20. Li Y., Sarkar F.H. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 2002, 8(7):2369-2377.
21. Okabe S., et al. Modulation of gene expression by (-)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol Pharm Bull 2001, 24(8):883-886.
22. Raffoul J.J., et al. Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest. BMC Cancer 2006, 6:107.
23. Orner G.A., Dashwood W.M., Dashwood R.H. Tumor-suppressing effects of antioxidants from tea. J Nutr 2004, 134(11):3177S-3178S.
24. Mentor-Marcel R., et al. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 2001, 61(18):6777-6782.
25. Han X., Liehr J.G., Bosland M.C. Induction of a DNA adduct detectable by 32P-postlabeling in the dorsolateral prostate of NBL/Cr rats treated with estradiol-17 beta and testosterone. Carcinogenesis 1995, 16(4):951-954.
26. Drago J.R. The induction of NB rat prostatic carcinomas. Anticancer Res 1984, 4(4-5):255-256.
27. Bosland M.C., Ford H., Horton L. Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol. Carcinogenesis 1995, 16(6):1311-1317.
28. Kenny A.M., et al. Soy proteins and isoflavones affect bone mineral density in older women: a randomized controlled trial. Am J Clin Nutr 2009.
29. Ofner P., Bosland M.C., Vena R.L. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes. Toxicol Appl Pharmacol 1992, 112(2):300-309.
30. Hernaez J., Xu M., Dashwood R. Effects of tea and chlorophyllin on the mutagenicity of N-hydroxy-IQ: studies of enzyme inhibition, molecular complex formation, and degradation/scavenging of the active metabolites. Environ Mol Mutagen 1997, 30(4):468-474.
31. Noble R.L. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res 1977, 37(6):1929-1933.
32. Bernoulli J., et al. Prostatic inflammation and obstructive voiding in the adult Noble rat: impact of the testosterone to estradiol ratio in serum. Prostate 2008, 68(12):1296-1306.
33. Palapattu G.S., et al. Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 2005, 26(7):1170-1181.
34. Tam N.N., Leav I., Ho S.M. Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat. Am J Pathol 2007, 171(4):1334-1341.
35. Karin M. NF-kappaB and cancer: mechanisms and targets. Mol Carcinog 2006, 45(6):355-361.
36. LaCasse E.C., et al. IAP-targeted therapies for cancer. Oncogene 2008, 27(48):6252-6275.
37. Jemal A., et al. Cancer statistics, 2007. CA Cancer J Clin 2007, 57(1):43-66.
38. Hedlund T.E., et al. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in Caucasian men. J Nutr 2005, 135(6):1400-1406.
39. Slavin J.L., et al. Influence of soybean processing, habitual diet, and soy dose on urinary isoflavonoid excretion. Am J Clin Nutr 1998, 68(6 Suppl):1492S-1495S.
40. Dashwood R.H. Frontiers in polyphenols and cancer prevention. J Nutr 2007, 137(1 Suppl):267S-269S.
41. Lambert J.D., et al. Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate. Carcinogenesis 2008, 29(10):2019-2024.
42. Bu-Abbas A., et al. Stimulation of rat hepatic UDP-glucuronosyl transferase activity following treatment with green tea. Food Chem Toxicol 1995, 33(1):27-30.
43. Xu M., Dashwood R.H. Chemoprevention studies of heterocyclic amine-induced colon carcinogenesis. Cancer Lett 1999, 143(2):179-183.
44. Hara Y. Influence of tea catechins on the digestive tract. J Cell Biochem Suppl 1997, 27:52-58.
45. Narayanan B.A., et al. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Clin Cancer Res 2004, 10(22):7727-7737.
46. Narayanan B.A., et al. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition. Prostate 2006, 66(3):257-265.
47. Kearney P.M., et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006, 332(7553):1302-1308.
48. Traversa G., et al. Gastroduodenal toxicity of different nonsteroidal antiinflammatory drugs. Epidemiology 1995, 6(1):49-54.
49. Cavalieri E.L., et al. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer. Carcinogenesis 2002, 23(2):329-333.
50. Soronen P., et al. Sex steroid hormone metabolism and prostate cancer. J Steroid Biochem Mol Biol 2004, 92(4):281-286.
51. Cavalieri E.L., Rogan E.G. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones. Ann N Y Acad Sci 2004, 1028:247-257.
52. Zhu B.T., Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 1998, 19(1):1-27.
53. Suh J., et al. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate 2002, 52(3):183-200.
54. Suh J., Rabson A.B. NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?. J Cell Biochem 2004, 91(1):100-117.
55. Kazi A., et al. Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem Pharmacol 2003, 66(6):965-976.
56. Messina M.J. Emerging evidence on the role of soy in reducing prostate cancer risk. Nutr Rev 2003, 61(4):117-131.
57. Adhami V.M., et al. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer. Cancer Res 2004, 64(23):8715-8722.
58. Adhami V.M., et al. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin Cancer Res 2009, 15(6):1947-1953.
59. O'Sullivan J., et al. The effect of green tea on oxidative damage and tumour formation in Lobund-Wistar rats. Eur J Cancer Prev 2008, 17(6):489-501.
60. Cohen L.A., et al. Effect of soy protein isolate and conjugated linoleic acid on the growth of Dunning R-3327-AT-1 rat prostate tumors. Prostate 2003, 54(3):169-180.
61. Siddiqui I.A., et al. Suppression of NFkappaB and its regulated gene products by oral administration of green tea polyphenols in an autochthonous mouse prostate cancer model. Pharm Res 2008, 25(9):2135-2142.
62. Allred C.D., et al. Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 2004, 25(9):1649-1657.
63. Murrill W.B., et al. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 1996, 17(7):1451-1457.
64. Zhou J.R., et al. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice. J Nutr 2003, 133(2):516-521.
65. Bode A.M., Dong Z. Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail. Cancer Prev Res (Phila Pa) 2009, 2(6):514-517.